NCT05452369

Brief Summary

Despite of analgesic effect of intravenous analgesic medications at intraoperative and postoperative time , The regional anesthetic techniquehas more benefits suchbetter control of Acute pain and hence less chronic pain and decreases the need for opioids and analgesics to preserve immune function which responsible for higher rates of infection and local recurrence, even metastasis . New regional anesthetic technique for modified radical mastectomy discovered recently called rhomboid intercostal nerve block that will compared against erector spinae plane block .

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
104

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Oct 2021

Geographic Reach
1 country

2 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2021

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

July 6, 2022

Completed
5 days until next milestone

First Posted

Study publicly available on registry

July 11, 2022

Completed
21 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2022

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2022

Completed
Last Updated

October 12, 2022

Status Verified

October 1, 2022

Enrollment Period

10 months

First QC Date

July 6, 2022

Last Update Submit

October 10, 2022

Conditions

Keywords

Modified Radical MastectomyRhomboid Intercostal Nerve BlockErector Spinae Plane Block .

Outcome Measures

Primary Outcomes (1)

  • The total analgesic requirements during the first 24 hours postoperative.

    All patients will receive standard postoperative analgesia (1gm paracetamol every 8 hours IV).

    0,2,4,6,8,10,12,16,20,24 hours postoperatively

Secondary Outcomes (1)

  • The duration of effective analgesia

    0,2,4,6,8,10,12,16,20,24 hours postoperatively

Study Arms (2)

rhomboid intercostal plane block

EXPERIMENTAL

as in intervention description

Drug: Rhomboid intercostal plane block

Erector spinae plane block

EXPERIMENTAL

As in intervention description

Drug: Rhomboid intercostal plane block

Interventions

\- 30 mL bupivacaine 0.25% will injected ultrasound-guided in rhomboid intercostal fascial plane .

Also known as: fascial plane block
Erector spinae plane blockrhomboid intercostal plane block

Eligibility Criteria

Age25 Years - 65 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsFemale patients undergoing modified radical mastectomy surgery
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • \- Female patients aged between 25-65 years.
  • ASA physical status I or II.
  • Scheduled for elective unilateral modified radical mastectomy

You may not qualify if:

  • \- Patient refusal.
  • Infection at the site of injection.
  • Hypersensitivity to the local anesthetic
  • Bleeding disorders.
  • Patients with cardiac, hepatic, and renal failure.
  • BMI ≥40 kg/m2
  • Patient with serum cr \> 1.5

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Mansoura University

Al Mansurah, Dakahlia Governorate, 35516, Egypt

Location

Mansoura University

Al Mansurah, Egypt

Location

MeSH Terms

Conditions

Pain, Postoperative

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and Symptoms

Study Officials

  • mohamed y makharita, MD

    Professor OFanesthesia Mansoura university

    STUDY DIRECTOR
  • ghada f amer, MD

    Assistant professor of anesthesia Mansoura university

    STUDY CHAIR
  • ahmed E Kamal, resident

    resident of anesthesia mansoura university

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
\- double-blind comparative study.
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: \- Two arms: rhomboid intercostal plane block is the first group Erector spinae plane block is the second group
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
associate professor of anesthesia

Study Record Dates

First Submitted

July 6, 2022

First Posted

July 11, 2022

Study Start

October 1, 2021

Primary Completion

August 1, 2022

Study Completion

December 1, 2022

Last Updated

October 12, 2022

Record last verified: 2022-10

Locations